Vitamin E-TPGS increases absorption flux of an HIV protease inhibitor by enhancing its solubility and permeability.
about
Drug Delivery Innovations for Enhancing the Anticancer Potential of Vitamin E Isoforms and Their DerivativesQuantification of antiretroviral drugs for HIV-1 in the male genital tract: current data, limitations and implications for laboratory analysis.Single-dose safety and pharmacokinetics of brecanavir, a novel human immunodeficiency virus protease inhibitorDosage and formulation issues: oral vitamin E therapy in childrenNanoparticles of Poly(Lactide-Co-Glycolide)-d-a-Tocopheryl Polyethylene Glycol 1000 Succinate Random Copolymer for Cancer Treatment.N-trimethyl chitosan chloride-coated liposomes for the oral delivery of curcumin.Copolymers of poly(lactic acid) and D-α-tocopheryl polyethylene glycol 1000 succinate-based nanomedicines: versatile multifunctional platforms for cancer diagnosis and therapy.An improved D-α-tocopherol-based nanocarrier for targeted delivery of doxorubicin with reversal of multidrug resistanceOral Delivery of DMAB-Modified Docetaxel-Loaded PLGA-TPGS Nanoparticles for Cancer Chemotherapy.Improved absorption and bioactivity of active compounds from an anti-diabetic extract of Artemisia dracunculus L.Bioavailability study of berberine and the enhancing effects of TPGS on intestinal absorption in rats.Fmoc-conjugated PEG-vitamin E2 micelles for tumor-targeted delivery of paclitaxel: enhanced drug-carrier interaction and loading capacityUltra rapidly dissolving repaglinide nanosized crystals prepared via bottom-up and top-down approach: influence of food on pharmacokinetics behavior.Synthesis, characterization, and in-vitro antitumor activity of the polyethylene glycol (350 and 1000) succinate derivatives of the tocopherol and tocotrienol isomers of Vitamin E.A covalently stabilized lipid-polycation-DNA (sLPD) vector for antisense oligonucleotide deliveryLipid-based colloidal carriers for peptide and protein delivery--liposomes versus lipid nanoparticles.Design and characterization of PEG-derivatized vitamin E as a nanomicellar formulation for delivery of paclitaxelImpact of osmotically active excipients on bioavailability and bioequivalence of BCS class III drugs.Development and characterization of lyophilized diazepam-loaded polymeric micelles.Microemulsions as drug delivery systems to improve the solubility and the bioavailability of poorly water-soluble drugs.Role of excipients in successful development of self-emulsifying/microemulsifying drug delivery system (SEDDS/SMEDDS).Transforming lipid-based oral drug delivery systems into solid dosage forms: an overview of solid carriers, physicochemical properties, and biopharmaceutical performance.Polymeric micelles: nanocarriers for cancer-targeted drug deliveryIn situ intestinal permeability and in vivo absorption characteristics of olmesartan medoxomil in self-microemulsifying drug delivery system.A novel oleanolic acid-loaded PLGA-TPGS nanoparticle for liver cancer treatment.Thiolated chitosan-modified PLA-PCL-TPGS nanoparticles for oral chemotherapy of lung cancer.An in vitro examination of the impact of polyethylene glycol 400, Pluronic P85, and vitamin E d-alpha-tocopheryl polyethylene glycol 1000 succinate on P-glycoprotein efflux and enterocyte-based metabolism in excised rat intestine.Permeability enhancing lipid-based co-solvent and SEDDS formulations of SQ641, an antimycobacterial agent.Efavirenz-loaded polymeric micelles for pediatric anti-HIV pharmacotherapy with significantly higher oral bioavailability [corrected].Enhanced solubility and oral absorption of sirolimus using D-α-tocopheryl polyethylene glycol succinate micelles.Effects of formulation and dosing strategy on amprenavir concentrations in the seminal plasma of human immunodeficiency virus type 1-infected men.Nanosuspension formulations for low-soluble drugs: pharmacokinetic evaluation using spironolactone as model compound.A comparison of intestinal lymphatic transport and systemic bioavailability of saquinavir from three lipid-based formulations in the anaesthetised rat model.Challenges associated with the evaluation of veterinary product bioequivalence: an AAVPT perspective.Effect of tocopheryl polyethylene glycol succinate on the percutaneous penetration of minoxidil from water/ethanol/polyethylene glycol 400 solutions.Preparation and characterization of progesterone dispersions using supercritical carbon dioxide
P2860
Q26824259-21970481-CE34-4EA4-BFEA-E5AEFC359EA1Q31135042-42C5B892-5ECC-43F1-9D1A-867FEA564175Q33435327-59D5F650-A4CB-4ABE-B8C4-EF8EF7BB63CEQ33587865-D6742641-BAC7-474E-A7E0-0195CFDE247DQ33948336-E89D86DB-2F95-46EB-B8AB-717A660C0F58Q34050685-BBEFC2AD-2535-4AB7-BB13-146B4EDFC79FQ34322427-5B1DD61A-F4F0-45B8-AE09-C6E1E45B1A68Q34714270-3A15D1BA-22D3-45C0-A243-0895F3218DDFQ35008164-DDF5F267-8A4C-407F-8718-EDC95F833A4DQ35087845-E1B09C5E-94D4-43E0-A6B0-09B96E12DA2BQ35100360-91E07787-CFCB-43FF-B335-099F18F0A65EQ35318179-34D1136E-BD24-44D1-903F-579F96D3E6CAQ35868308-5E3E786D-5CF7-44B4-A9D7-D9C315D631EEQ36250750-75847F19-7F6F-47BA-A9A4-099A9DF3705BQ36691274-A9B3D815-4F58-4D1B-82DD-8416B7C95DBFQ37059900-D0C1AAD9-5243-4A6C-A4E8-3433F137DBD1Q37185400-876A1E9F-A87E-4860-9B08-26159CB10B5BQ37207781-52EEEFC6-CF42-4A4C-BFAC-C531A3DB3628Q37538899-E8F1BECF-1AA5-4A3D-9587-FAF855EF76C8Q37702234-45DD4274-31E5-40D8-8600-AF3C1472A298Q37988960-8B2C210A-7A66-4625-91FF-E2001CD022D9Q38115195-EE7E88F9-B4A1-4F52-8F1E-FDFC091AAF07Q38202058-70004443-1D45-4FE5-AB7C-83A1DE6F91F9Q38469693-6C69C4DE-256B-4C47-A504-3D6E880CA97FQ38975201-5A305015-366F-4880-89FD-F4AD0A4B1BA3Q41071914-ED68DF56-57AD-4C38-8D3E-7B8890EBBE50Q42050629-0CE0D565-E6A3-4EC3-B952-EB996F34ECB4Q42209752-765ECF69-8FD7-4387-9EF5-6B9D5A4E25A0Q43213058-03C81DF6-62A4-446C-9409-7B36CC74D7A7Q43410189-C4DD8291-DCBB-4AB2-AAFD-7CCEC3FA3099Q44119555-E6669355-78E5-4104-9FA6-ED1147263FDBQ46437949-02FFDC4B-9DBA-434A-BC9A-CDB1946E1E4BQ48685663-9B0F00DC-088B-48A4-AD59-1D464AE0A6A8Q50697363-8AF7F67F-B793-418C-8F62-955CACE3BC3FQ51941045-7150DE9C-B7AC-45F1-B737-A6DAC6517CC1Q57164401-C4EB4D29-C66E-42B1-8E83-803CA7D62DAE
P2860
Vitamin E-TPGS increases absorption flux of an HIV protease inhibitor by enhancing its solubility and permeability.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh-hant
name
Vitamin E-TPGS increases absor ...... s solubility and permeability.
@en
Vitamin E-TPGS increases absor ...... s solubility and permeability.
@nl
type
label
Vitamin E-TPGS increases absor ...... s solubility and permeability.
@en
Vitamin E-TPGS increases absor ...... s solubility and permeability.
@nl
prefLabel
Vitamin E-TPGS increases absor ...... s solubility and permeability.
@en
Vitamin E-TPGS increases absor ...... s solubility and permeability.
@nl
P2093
P356
P1476
Vitamin E-TPGS increases absor ...... s solubility and permeability.
@en
P2093
A Bridgers
P304
P356
10.1023/A:1018939006780
P577
1999-12-01T00:00:00Z